Keywords
Reproductive medicine, Pain
https://mc.manuscriptcentral.com/bmj
BMJ
Confidential: For Review Only
1
1 BMJ: Easily Missed: Endometriosis, an update
2 Authors
3 Louie Ye1,2
4 Job title: RANZCOG Trainee/Clinical Fellow
5 Lucy H R Whitaker3
6 Job title: NES/CSO Clinical Lecturer in Obstetrics & Gynaecology
7 Rebecca L Mawson4
8 Job title: GP & Academic Training Fellow
9 Martha Hickey1,2
10 Job title: Professor of Obstetrics and Gynaecology
11
12 Affiliations
13 1. The Royal Women’s Hospital, Melbourne, Victoria, Australia
14 2. The Department of Obstetrics and Gynaecology, University of Melbourne and the
15 Royal Women’s Hospital, Victoria, Australia
16 3. MRC Centre for Reproductive Health, Queen's Medical Research Institute, University
17 of Edinburgh, 49 Little France Crescent, EH16 4TJ
18 4. The Academic Unit of Primary Medical Care, The University of Sheffield, Samuel Fox
19 House, Sheffield, S5 7AU, UK.
20
21 Corresponding author:
[email protected]
22
23 Declarations
24 The Corresponding Author has the right to grant on behalf of all authors and does grant on
25 behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in
26 all forms, formats and media (whether known now or created in the future), to i) publish,
27 reproduce, distribute, display and store the Contribution, ii) translate the Contribution into
28 other languages, create adaptations, reprints, include within collections and create
29 summaries, extracts and/or, abstracts of the Contribution, iii) create any other derivative
30 work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v)
31 the inclusion of electronic links from the Contribution to third party material where-ever it
32 may be located; and, vi) licence any third party to do any or all of the above.
33
34 We have read and understood the BMJ policy on declaration of interests and declare the
35 following interests: None
36
37 Those named as authors have fulfilled all 4 ICMJE authorship criteria.
38
39 Within our article, we use the terms ‘women’ and ‘women’s health’. However, we
40 acknowledge that it is necessary for all assigned female at birth, including those whose gender
41 identity does not align with the sex they were assigned at birth, to access evidence-based care
42 in order to maintain their gynaecological health and reproductive wellbeing.
43
44
45
46
47
Page 1 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
2
48 Case presentation
49 A 24-year-old woman presents to a new GP with several years of pain during sexual
50 intercourse and increasingly painful periods affecting her mood, relationships and work. The
51 pain persisted despite simple analgesia. She has had multiple contacts with healthcare
52 professionals without a diagnosis or effective management. Her new GP suspects
53 endometriosis. A transvaginal ultrasound (TVUS) and a three-month trial of combined oral
54 contraceptive (COCP) is recommended. No pathology is identified on ultrasound. After three
55 months, there was little improvement, and a gynaecology referral was offered. Subsequent
56 laparoscopy reveals superficial peritoneal endometriosis, and the patient opted for
57 concurrent excisional surgery with insertion of a levonorgestrel-releasing intrauterine
58 system, a choice reflecting her previous treatment experiences and current contraceptive
59 requirements.
60
61
What is it?
62
63 Endometriosis is defined as the “presence of endometrial-like tissue outside the uterus”(1).
64 There are three sub-types: Superficial peritoneal, deep and ovarian (endometrioma cysts)
65 though symptom severity and disease sub-type and extent are commonly discordant (1).
66 Less frequently, endometriosis occurs in other anatomical locations such as the thorax or
67 previous surgical incision sites (1).
68
69 Estimates of disease prevalence vary widely due to inconsistent presentation compounded
70 by diagnostic challenges. In particular, the requirement of laparoscopy to make a diagnosis.
71 The estimated population prevalence of endometriosis is 1 in 10 (2) but is higher in selected
72 populations. For example in those with subfertility prevalence may be up to 50% (3).
73
74 Typical gynaecological presentations include painful periods and sub-fertility (1,4). Other
75 symptoms include pain with sex and with defecation or urination which may be cyclical, and
76 systemic manifestations such as fatigue (1,4,5). Sensitisation of central pathways may lead
77 to chronic pain syndromes (6). Long-term consequences include impaired quality of life,
78 anxiety, depression and self-harm(7,8). However, not all individuals with endometriosis
79 have pain symptoms, particularly in the context of sub-fertility.
80
81 Factors contributing to sub-fertility may include reduced ovarian reserve, altered
82 implantation and adhesion-related tubal occlusion, as well as decreased frequency of coitus
83 due to associated pain(9). Endometriosis is commonly missed, leading to diagnostic delays.
84 This article will discuss how the protean presenting symptoms and diagnostic criteria
85 contribute to this delay. Endometriosis associated infertility will not be explicitly discussed
86 because this diagnosis is commonly made during fertility investigations.
87
88
Why is it missed?
89 The average diagnostic delay is seven years from the onset of symptoms to definitive
90 diagnosis with variation between countries (10). In 2020, the UK diagnostic delay was eight
91 years, which is unchanged in a decade (11). An important contributing factor is the delay
92 between primary presentation and diagnostic testing (12–15). One third of patients had
93 consulted their GP six or more times before referral, with 39% having two or more
94 gynaecological referrals before a definitive diagnosis (14).
Page 2 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
3
95 Endometriosis is difficult to diagnose clinically as symptoms are both common and non-
96 specific(15,16) and may be attributed to other conditions (17). For example, endometriosis
97 may mimic or cause IBS, a common condition in primary care(17). The variable nature of
98 presenting symptoms may lead them to be dismissed as functional or psychosomatic
99 (12,13). Women consistently report difficulties in convincing doctors about the severity of
100 their symptoms. This is compounded by clinicians dismissing or normalising symptoms such
101 as painful periods (11,18). Affected women may also believe that their menstrual symptoms
102 are normal (15). Diagnostic delay is even more common in adolescents(19), possibly due to
103 a false belief that endometriosis takes time to cause symptoms after the onset of
104 menarche(20). Cultural barriers may lead to reluctance or difficulty in reporting menstrual
105 and sexual symptoms (11,18). The lack of reliable non-invasive tests likely contributes to
106 delays in diagnosis and treatment(21,22). This is intensified by the variation and
107 methodological quality of endometriosis guidelines leading to different diagnostic
108 criteria(23).
109 Why does it matter?
110 Endometriosis may cause considerable suffering, distress and economic hardship for
111 individuals(6,24). Diagnostic delays may have a significant impact socially and
112 psychologically (25) and longer delay is associated with more advanced disease (26).
113 Chronic pain may impair quality of life, reduce productivity and workforce participation, and
114 contribute to financial hardship (Figure 1)(6,7,11). In the UK, the economic impact of
115 endometriosis is estimated at around £8.2 billion per year, primarily due to absenteeism
116 from work and healthcare costs (27). Direct treatment costs are comparable to conditions
117 such as Type 2 diabetes or rheumatoid arthritis (27).
118
119 Around 30% of women with infertility have endometriosis (28), increasing to 50% in those
120 with regular menstrual cycles and male partners normospermia(3). Delayed diagnosis may
121 reduce the chance of pregnancy by 33% (29).
122
123 With such profound consequences for individuals and society, "reducing delayed diagnosis"
124 is a priority area for research (11,30). Early diagnosis and prompt treatment might mitigate
125 the psychosocial and economic burden associated with delayed management of
126 endometriosis-related pain (12,15,29). However, it is not known whether earlier treatment
127 affects the natural history of endometriosis or reduces the incidence of chronic pain
128 syndromes
129
130
How is it diagnosed?
131 There is a lack of consensus about how endometriosis should be diagnosed. In the UK,
132 guidelines from the National Institute for Health and Care Excellence (NICE) and the
133 European Society of Human Reproduction and Embryology (ESHRE) advise that laparoscopy
134 is the gold standard diagnostic tool with histological confirmation (4,13). Limited access and
135 cost of laparoscopy contribute to delayed diagnosis and others have argued that clinical and
136 radiographic features are sufficient particularly for ovarian and deep sub-types (18).
137 Improving diagnosis and non-invasive screening tools is a top 10 research priority for the UK
138 (30).
139
Page 3 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
4
140 Clinical features
141 Initial suspicion and clinical diagnosis of endometriosis relies on a combination of clinical
142 history, physical examinations, and imaging findings. Isolated pelvic examination in primary
143 care is often uninformative (5). A normal pelvic exam or inability to perform an examination
144 should not delay gynaecological referral(4).
145 Management in primary care may include ruling out conditions such as pelvic infection,
146 pregnancy, and inflammatory or irritable bowel disease. Previous presentations may also be
147 informative. A study of primary care records found that women subsequently diagnosed
148 with endometriosis were likely to have had multiple consults with menstrual pain within a
149 12-month period, as well as gastrointestinal symptoms associated with menstruation (31).
150 Managing complexity and uncertainty within the initial presentations of endometriosis
151 symptoms underpins consultations in general practice(32).
152 Investigations
153 There are currently no biomarkers for endometriosis with adequate specificity or sensitivity,
154 although this is an active area of research (21)(33). NICE and ESHRE guide against measuring
155 Ca125 due to lack of sensitivity and specificity (4). NICE recommends transvaginal
156 ultrasound (TVUS) as first-line imaging for suspected endometriosis (4). TVUS may exclude
157 other potential conditions such as cysts and may identify ovarian endometriomas.
158 Specialists in TVUS report a sensitivity of 79% and specificity of 94% for deep endometriosis
159 and 3-D ultrasound may increase sensitivity to 87% (22,34). However, Access to specialist
160 ultrasonography is limited in most settings.
161
162 Where TVUS is declined or inappropriate trans-abdominal ultrasound should be offered but
163 has a lower sensitivity and specificity than TVUS (4). Ovarian and deep endometriosis may
164 be visible on MRI (22). However, only around 17-44% of women with endometriosis present
165 with endometriomas (35,36).
166 Laparoscopy for direct visualisation of lesions remains gold standard diagnostic tool(4,13).
167 However, access to laparoscopy contributes to the delay in diagnosis, is costly, invasive and
168 carries surgical risks (37). In view of this, laparoscopy may not be required for diagnosis if
169 imaging identifies endometriomas or deep disease. Similarly, laparoscopy may not be
170 indicated for women with symptoms controlled by medical therapy if the patient is in
171 agreement with a ‘working diagnosis’ of endometriosis(38).
172
How is it managed?
173 Management in primary and tertiary care should be holistic, addressing symptoms and
174 offering psychological support, individualised to patient wishes and fertility priorities. In
175 primary care, NICE recommends a 3-month trial of paracetamol or NSAIDs alone or
176 combined with a COCP or continuous progestogen for pain suggestive of endometriosis(39).
177 Patient Decision aids have been developed to support the choice of hormonal preparation
178 (4).
179
180 Gynaecology referral is recommended when this initial management is ineffective or
181 contraindicated. Women with severe or recurrent symptoms, endometriomas (>3cm),
182 urinary tract/bowel involvement or infertility plus symptoms of endometriosis should also
183 be referred to a specialist endometriosis centre if available(4). Medical treatments such as
Page 4 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
5
184 LNG-IUS and GnRHa may be used alone or in addition to surgery (pre- & post-operatively) to
185 manage pain and reduce recurrence (40,41).
186
187 Laparoscopic excisional/ablative surgery is the mainstay of surgical treatment. Complex
188 surgery for deep endometriosis involving the bowel, bladder or ureter is best managed
189 within a specialist endometriosis centre(42). The risk of serious surgical complications
190 depends on the extent, distribution and depth of disease, but is around 7% for surgical
191 resection of deep endometriosis(42). Surgery may not be definitive and up to 50% report
192 persistent symptoms at 5 years, indicating the importance of informed choice and follow-up
193 care (43,44). Surgery has not been shown to improve fertility(39). A 2020 systematic review
194 concluded that laparoscopic surgical management did not improve live birth rates and
195 ovarian surgery may impair fertility (43). There are currently ongoing clinical trials examining
196 the risks and benefits of sub-type specific surgery to improve pain, quality of life and fertility
197 outcomes to inform evidenced-base and joint-decision making.
198
199
References
200 1. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic
201 prospects. Vol. 184, Cell. 2021.
202 2. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North
203 Am. 1997;24(2):235–58.
204 3. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T.
205 High prevalence of endometriosis in infertile women with normal ovulation and
206 normospermic partners. Fertil Steril. 2009 Jul;92(1):68–74.
207 4. National Institute for Health and Care Excellence - NICE. Endometriosis: diagnosis and
208 management. 2017.
209 5. RANZCOG. Endometriosis Clinical Practice Guideline Australia [Internet]. 2021 [cited
210 2022 Apr 19]. Available from:
211 https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s
212 Health/Statement and guidelines/Clinical - Gynaecology/Endometriosis-clinical-
213 practice-guideline.pdf?ext=.pdf
214 6. Coxon L, Horne AW, Vincent K. Pathophysiology of endometriosis-associated pain: A
215 review of pelvic and central nervous system mechanisms. Best Pract Res Clin Obstet
216 Gynaecol. 2018 Aug 1;51:53–67.
217 7. Estes SJ, Huisingh CE, Chiuve SE, Petruski-Ivleva N, Missmer SA. Depression, Anxiety,
218 and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-
219 Cohort Study. Am J Epidemiol. 2021;190(5):843–52.
220 8. Nnoaham KE, Hummelshoj L, Webster P, D’Hooghe T, De Cicco Nardone F, De Cicco
221 Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a
222 multicenter study across ten countries. Fertil Steril. 2011;96(2).
223 9. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of
224 pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand.
225 2017 Jun 1;96(6):659–67.
226 10. Zondervan KT, Becker CM, Missmer SA. Endometriosis. Longo DL, editor. N Engl J
227 Med. 2020 Mar 26;382(13):1244–56.
228 11. APPG. APPG on Endometriosis Inquiry Report 2020. Endometriosis in the UK: time for
229 change (October 2020) - Women’s health - Patient Safety Learning - the hub. 2020.
Page 5 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
6
230 12. Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s
231 experiences of reaching a diagnosis of endometriosis. Fertil Steril. 2006
232 Nov;86(5):1296–301.
233 13. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al.
234 ESHRE guideline: management of women with endometriosis. Hum Reprod.
235 2014;29(3):400–12.
236 14. Pugsley Z, Ballard K. Management of endometriosis in general practice: the pathway
237 to diagnosis. Br J Gen Pract. 2007 Jun;57(539):470.
238 15. Staal AHJ, Van Der Zanden M, Nap AW. Diagnostic Delay of Endometriosis in the
239 Netherlands. Gynecol Obstet Invest. 2016 Jul 1;81(4):321–4.
240 16. Abbas S, Ihle P, Köster I, Schubert I. Prevalence and incidence of diagnosed
241 endometriosis and risk of endometriosis in patients with endometriosis-related
242 symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J
243 Obstet Gynecol Reprod Biol. 2012;160(1):79–83.
244 17. Ballard KD, Seaman HE, De Vries CS, Wright JT. Can symptomatology help in the
245 diagnosis of endometriosis? Findings from a national case-control study--Part 1.
246 BJOG. 2008 Oct;115(11):1382–91.
247 18. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical
248 diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019 Apr
249 1;220(4):354.e1-354.e12.
250 19. Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis
251 Diagnosis in the United States. J Womens Health (Larchmt). 2017 Jul 1;26(7):788–97.
252 20. Saridotan E. Endometriosis in teenagers. Women’s Heal. 2015;11(5):705–9.
253 21. Nisenblat V, Bossuyt PMM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. Blood
254 biomarkers for the non-invasive diagnosis of endometriosis. Cochrane database Syst
255 Rev. 2016 May 1;2016(5).
256 22. Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML. Imaging modalities for
257 the non-invasive diagnosis of endometriosis. Cochrane database Syst Rev. 2016 Feb
258 26;2(2).
259 23. Hirsch M, Begum MR, Paniz, Barker C, Davis CJ, Duffy JMN. Diagnosis and
260 management of endometriosis: a systematic review of international and national
261 guidelines. BJOG An Int J Obstet Gynaecol. 2018 Apr 1;125(5):556–64.
262 24. Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed
263 Endometriosis in the United States: National Estimates from a Cross-Sectional Survey
264 of 59,411 Women. Gynecol Obstet Invest. 2017 Sep 1;82(5):453–61.
265 25. Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and
266 psychological impact of endometriosis on women’s lives: a critical narrative review.
267 Hum Reprod Update. 2013 Nov;19(6):625–39.
268 26. Matsuzaki S, Canis M, Pouly JL, Rabischong B, Botchorishvili R, Mage G. Relationship
269 between delay of surgical diagnosis and severity of disease in patients with
270 symptomatic deep infiltrating endometriosis. Fertil Steril. 2006 Nov 1;86(5):1314–6.
271 27. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The
272 burden of endometriosis: costs and quality of life of women with endometriosis and
273 treated in referral centres. Hum Reprod. 2012;27(5):1292–9.
274 28. Gruppo italiano per lo studio dell’endometriosi. Endometriosis: Prevalence and
Page 6 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
7
275 anatomical distribution of endometriosis in women with selected gynaecological
276 conditions: Results from a multicentric italian study. Hum Reprod. 1994;9(6).
277 29. Moss KM, Doust J, Homer H, Rowlands IJ, Hockey R, Mishra GD. Delayed diagnosis of
278 endometriosis disadvantages women in ART: a retrospective population linked data
279 study. Hum Reprod. 2021 Nov 18;36(12):3074–82.
280 30. Horne AW, Saunders PTK, Abokhrais IM, Hogg L. Top ten endometriosis research
281 priorities in the UK and Ireland. Lancet (London, England). 2017 Jun
282 3;389(10085):2191–2.
283 31. Burton C, Iversen L, Bhattacharya S, Ayansina D, Saraswat L, Sleeman D. Pointers to
284 earlier diagnosis of endometriosis: a nested case-control study using primary care
285 electronic health records. Br J Gen Pract. 2017 Dec 1;67(665):e816–23.
286 32. Dixon S, McNiven A, Talbot A, Hinton L. Navigating possible endometriosis in primary
287 care: a qualitative study of GP perspectives. Br J Gen Pract. 2021 Sep 1;71(710):e668–
288 76.
289 33. Tian Z, Chang XH, Zhao Y, Zhu HL. Current biomarkers for the detection of
290 endometriosis. Chin Med J (Engl). 2020;133(19):2346–52.
291 34. Guerriero S, Saba L, Ajossa S, Peddes C, Angiolucci M, Perniciano M, et al. Three-
292 dimensional ultrasonography in the diagnosis of deep endometriosis. Hum Reprod.
293 2014;29(6).
294 35. Jenkins S, Olive D. Endometriosis: pathogenetic implications of the anatomic
295 distribution. Obstet Gynecol. 1986;67(3):335–8.
296 36. Redwine DB. Ovarian endometriosis: A marker for more extensive pelvic and
297 intestinal disease. Fertil Steril. 1999;72(2).
298 37. Royal Colleges of Obstetrics and Gynaecology. Diagnostic Laparoscopy (Consent
299 Advice No. 2) [Internet]. [cited 2022 Apr 25]. Available from:
300 https://www.rcog.org.uk/guidance/browse-all-guidance/consent-advice/diagnostic-
301 laparoscopy-consent-advice-no-2/
302 38. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and
303 management of endometriosis. Nat Rev Endocrinol 2019 1511. 2019 Sep
304 5;15(11):666–82.
305 39. Kalaitzopoulos DR, Samartzis N, Kolovos GN, Mareti E, Samartzis EP, Eberhard M, et
306 al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC
307 Womens Health. 2021 Dec 1;21(1).
308 40. Chen I, Veth VB, Choudhry AJ, Murji A, Zakhari A, Black AY, et al. Pre- and postsurgical
309 medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2020 Nov
310 18;2020(12).
311 41. Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A. Endometriosis
312 recurrence following post-operative hormonal suppression: a systematic review and
313 meta-analysis. Hum Reprod Update. 2021 Jan 4;27(1):96–107.
314 42. Byrne D, Curnow T, Smith P, Cutner A, Saridogan E, Clark TJ. Laparoscopic excision of
315 deep rectovaginal endometriosis in BSGE endometriosis centres: a multicentre
316 prospective cohort study. BMJ Open. 2018 Apr 1;8(4):e018924.
317 43. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JMN. Laparoscopic surgery for
318 endometriosis. Cochrane database Syst Rev. 2020 Oct 23;10(10).
319 44. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update.
Page 7 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
8
320 2009;15(4):441–61.
321 45. Rowlands IJ, Abbott JA, Montgomery GW, Hockey R, Rogers P, Mishra GD. Prevalence
322 and incidence of endometriosis in Australian women: a data linkage cohort study.
323 BJOG An Int J Obstet Gynaecol. 2021 Mar 1;128(4):657–65.
324
Page 8 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
9
325
326
How common is it
A US cross-sectional survey estimated the prevalence of diagnosed endometriosis at
6.1%(24), with a predominant symptom burden in those aged 18-29. This was
corroborated by an Australian study reporting that 6.3% of women aged 40-44 years have
confirmed endometriosis (45).
More prevalent in certain patient groups (2)
Asymptomatic women - 2 to 11%
Women with infertility - 5 to 50%
Women hospitalised for pelvic pain - 5 to 21%
Women with chronic pelvic pain - 50%–75%
327
What you need to know
1. No non-invasive diagnostic tools are available to identify endometriosis,
laparoscopic biopsy of endometriotic lesions remains the gold standard for
diagnosis
2. Consider endometriosis in women of reproductive age with abdomino-pelvic pain
associated with menstruation, sexual intercourse, urination, defecation, and
infertility.
3. Pain from suspected endometriosis can be managed in primary care with initial
treatment with hormonal contraceptive methods including LNG-IUS combined
with analgesia without laparoscopic confirmation
328
How patients were involved in the creation of this article
We asked two people living with endometriosis in the UK for comments on an early draft
of this paper. In response to their comments, we revised the case to highlight the fact it
often takes several years and many visits for endometriosis to be suspected &
investigated. We also sought to highlight the impact of endometriosis on quality of life
and the recurrence/ongoing impact after surgical excision.
329
Education into practice
How do you communicate with your patients about their menstrual symptoms?
How do you make a provisional diagnosis of endometriosis?
What are the initial treatments you can offer and how would you adapt these for
different patients?
330
331 Figure 1
Page 9 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
10
332
333
334 Reproduced with copyright permission from Horne & Saunders 2019 (28).
335
Page 10 of 10
https://mc.manuscriptcentral.com/bmj
BMJ
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60